市場調查報告書

胞外體診斷·治療市場:COVID-19影響與全球市場分析:2027年前的預測

Exosome Diagnostics and Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Service; Application; & End User

出版商 The Insight Partners 商品編碼 935343
出版日期 內容資訊 英文 149 Pages
訂單完成後即時交付
價格
胞外體診斷·治療市場:COVID-19影響與全球市場分析:2027年前的預測 Exosome Diagnostics and Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Service; Application; & End User
出版日期: 2020年04月24日內容資訊: 英文 149 Pages
簡介

胞外體診斷·治療市場預測將從2019年的4,163萬美元,到2027年達到3億5,891萬美元,2020年∼2027年間預測將以年複合成長率32.2%的速度成長。

本報告提供全球胞外體診斷·治療市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 簡介

第2章 重要的要點

第3章 調查手法

第4章 全球胞外體診斷·治療市場:市場形勢

  • 概要
  • PEST分析

第5章 全球胞外體診斷·治療市場:主要的市場動態

  • 主要的推動市場要素
  • 主要的阻礙市場要素
  • 主要市場機會
  • 未來趨勢
  • 影響分析

第6章 胞外體診斷·治療市場:全球分析

  • 全球胞外體診斷·治療市場收益預測與分析
  • 全球胞外體診斷·治療市場:各地區 - 預測與分析
  • 主要企業的市場定位

第7章 胞外體診斷·治療市場分析:各用途

  • 概要
  • 各用途
  • 診斷
  • 治療藥

第8章 胞外體診斷·治療市場分析:各產品

  • 概要
  • 各產品
  • 設備
  • 試劑
  • 軟體

第9章 胞外體診斷·治療市場分析:各終端用戶

  • 概要
  • 各終端用戶
  • 癌症研究所
  • 醫院
  • 診斷中心
  • 其他

第10章 胞外體診斷·治療市場:地區分析

  • 北美:胞外體診斷·治療市場
  • 歐洲:胞外體診斷·治療市場
  • 亞太地區:胞外體診斷·治療市場
  • 中東·非洲:胞外體診斷·治療市場
  • 中南美:胞外體診斷·治療市場

第11章 全球胞外體診斷·治療市場上COVID-19大流行病的影響

  • 北美:COVID-19大流行病的影響評估
  • 歐洲:COVID-19大流行病的影響評估
  • 亞太地區:COVID-19大流行病的影響評估
  • 其他地區:COVID-19大流行病的影響評估

第12章 胞外體診斷·治療市場:產業形勢

  • 概要
  • 成長策略
  • 無機的成長策略
  • 內部成長策略

第13章 企業簡介

第14章 附錄

目錄
Product Code: TIPRE00005514

The exosome diagnostic and therapeutic market was valued at US$ 41.63 million in 2019 and is expected to grow at a CAGR of 32.2% from 2020 to 2027 to reach US$ 358.91 million by 2027.

Driving factors of the exosome diagnostic and therapeutic market are greater precision and advantages over traditional methods of diagnosis and therapeutics and increasing number of research activities in the field of exosomes. However, poor infrastructure and lack of expertise required for isolation of exosomes are expected to restrain the growth of the market during the forecast period.

Exosomes are distinct populations of tiny membranous vesicles, released into the extracellular space by most cells, which get eventually accumulated in the body fluid circulation. By acting as cellular messengers, they play a role in vital physiological functions by transporting information between different cell types. Several healthcare organizations and industry players are implementing constructive strategies to boost the research and development pertaining to exosome applications. For instance, in October 2019, the American Type Culture Collection (ATCC), a premier global biological materials and information resource and standards organization, launched a new range of human-derived cell-specific exosomes to serve as reference materials for boosting drug and diagnostics development activities.

The global exosome diagnostic and therapeutics segmented by application, product, and end user. The exosome diagnostic and therapeutic market, by application, is further segmented into diagnostic applications and therapeutic applications. The diagnostic segment held a larger share of the market in 2019. Also, the diagnostic segment is anticipated to register a higher CAGR in the market during the forecast period. Based on product, the market is sub segmented into instruments, reagents, and software. The instruments segment held the largest share of the market in 2019, whereas the software segment is estimated to register the highest CAGR in the market during the forecast period. Based on end user, the exosome diagnostic and therapeutic market is further segmented into cancer institute, hospitals, diagnostic centers, and others. The cancer institute segment held the largest share of the market in 2019and is also projected to register the fastest growth.

A few essential primary and secondary sources included in the report are European Medical Association, Center for Drug Evaluation and Research and European Federation of Pharmaceuticals Industries Associations.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the exosome diagnostic and therapeutic market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global exosome diagnostic and therapeutic market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Exosome diagnostic and therapeutic Market - By Application
    • 1.3.2 Global Exosome diagnostic and therapeutic Market - By Product
    • 1.3.3 Global Exosome diagnostic and therapeutic Market - By End User
    • 1.3.4 Global Exosome Diagnostic and Therapeutic Market - By Geography

2. Exosome Diagnostic And Therapeutic Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Exosome Diagnostic and Therapeutic Market - Market Landscape

  • 4.1 Overview
  • 4.2 Pest Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis

5. Global Exosome Diagnostic and Therapeutic Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
    • 5.1.2 Rise in Research and Development Activities
  • 5.2 Key Market Restraints
    • 5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
  • 5.4 Future Trends
    • 5.4.1 Automation of Exosome Isolation Process
  • 5.5 Impact analysis

6. Exosome Diagnostic and Therapeutic Market- Global Analysis

  • 6.1 Global Exosome Diagnostic and Therapeutic Market Revenue Forecast And Analysis
  • 6.2 Global Exosome Diagnostic and Therapeutic Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Exosome Diagnostic and Therapeutic Market Analysis - By Application

  • 7.1 Overview
  • 7.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
  • 7.3 Diagnostic
    • 7.3.1 Overview
    • 7.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)
  • 7.4 Therapeutic
    • 7.4.1 Overview
    • 7.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)

8. Exosome Diagnostic and Therapeutic Market Analysis - By Product

  • 8.1 Overview
  • 8.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
  • 8.3 Instruments
    • 8.3.1 Overview
    • 8.3.2 Instruments: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • 8.4 Reagents
    • 8.4.1 Overview
    • 8.4.2 Reagents: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • 8.5 Software
    • 8.5.1 Overview
    • 8.5.2 Software: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

9. Exosome Diagnostic and Therapeutic Market Analysis - By End User

  • 9.1 Overview
  • 9.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
  • 9.3 Cancer Institutes
    • 9.3.1 Overview
    • 9.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • 9.4 Hospitals
    • 9.4.1 Overview
    • 9.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • 9.5 Diagnostic Centres
    • 9.5.1 Overview
    • 9.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • 9.6 Other End User
    • 9.6.1 Overview
    • 9.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

10. Exosome Diagnostic and Therapeutic Market - Geographic Analysis

  • 10.1 North America: Exosome Diagnostic and Therapeutic Market
    • 10.1.1 Overview
    • 10.1.2 North America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
    • 10.1.3 North America: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
    • 10.1.4 North America: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
    • 10.1.5 North America: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.1.6 North America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
    • 10.1.7 US: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.1.7.1 US: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.1.7.2 US: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.1.7.3 US: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.1.7.4 US: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.1.8 Canada: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.1.8.1 Canada: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.1.8.2 Canada: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.1.8.3 Canada: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.1.8.4 Canada: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.1.9 Mexico: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.1.9.1 Mexico: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.1.9.2 Mexico: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.1.9.3 Mexico: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.1.9.4 Mexico: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
  • 10.2 Europe: Exosome Diagnostic and Therapeutic Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
    • 10.2.3 Europe: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
    • 10.2.4 Europe: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
    • 10.2.5 Europe: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.2.6 Europe: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
    • 10.2.7 Germany: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.7.1 Germany: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.7.2 Germany: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.2.7.3 Germany: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.2.7.4 Germany: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.2.8 France: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.8.1 France: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.8.2 France: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.2.8.3 France: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.2.8.4 France: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.2.9 UK: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.9.1 UK: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.9.2 UK: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.2.9.3 UK: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.2.9.4 UK: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.2.10 Italy: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.10.1 Italy: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.10.2 Italy: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.2.10.3 Italy: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.2.10.4 Italy: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.2.11 Spain: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.11.1 Spain: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.2.11.2 Spain: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.2.11.3 Spain: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.2.11.4 Spain: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
  • 10.3 Asia Pacific: Exosome Diagnostic and Therapeutic Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
    • 10.3.3 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
    • 10.3.4 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
    • 10.3.5 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.3.6 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
    • 10.3.7 China: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.7.1 China: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.7.2 China: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.3.7.3 China: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.3.7.4 China: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.3.8 Japan: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.8.1 Japan: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.8.2 Japan: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.3.8.3 Japan: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.3.8.4 Japan: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.3.9 India: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.9.1 India: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.9.2 India: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.3.9.3 India: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.3.9.4 India: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.3.10 South Korea: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.10.1 South Korea: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.10.2 South Korea: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.3.10.3 South Korea: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.3.10.4 South Korea: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.3.11 Australia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.11.1 Australia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.3.11.2 Australia: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.3.11.3 Australia: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.3.11.4 Australia: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
  • 10.4 Middle East and Africa: Exosome Diagnostic and Therapeutic Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
    • 10.4.3 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
    • 10.4.4 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
    • 10.4.5 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.4.6 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
    • 10.4.7 UAE: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.4.7.1 UAE: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.4.7.2 UAE: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.4.7.3 UAE: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.4.7.4 UAE: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.4.8 Saudi Arabia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.4.8.1 Saudi Arabia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.4.8.2 Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.4.8.3 Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.4.8.4 Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.4.9 South Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.4.9.1 South Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.4.9.2 South Africa: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.4.9.3 South Africa: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.4.9.4 South Africa: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
  • 10.5 South and Central America: Exosome Diagnostic and Therapeutic Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
    • 10.5.3 South and Central America: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
    • 10.5.4 South and Central America: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
    • 10.5.5 South and Central America: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.5.6 South and Central America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
    • 10.5.7 Brazil: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.5.7.1 Brazil: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.5.7.2 Brazil: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.5.7.3 Brazil: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.5.7.4 Brazil: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
    • 10.5.8 Argentina: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.5.8.1 Argentina: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
      • 10.5.8.2 Argentina: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
      • 10.5.8.3 Argentina: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
      • 10.5.8.4 Argentina: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)

11. Impact Of COVID-19 Pandemic On Global Exosome Diagnostic And Therapeutic Market

  • 11.1 North America: Impact assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
  • 11.4 Rest of World: Impact assessment of COVID-19 Pandemic

12. Exosome Diagnostic and Treatment Market -Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies In The Exosome diagnostic and treatment Market, 2017-2020
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Cell Guidance Systems
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Bioregenerative Sciences
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Evomic Science LLC
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Norgen Biotek Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Miltenyi Biotec
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Therapeutic Solutions International, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 SWOT Analysis
    • 13.6.5 Key Developments
  • 13.7 Aethlon Medical, Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 RENEURON GROUP PLC
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 ITH, Immune Therapy Holdings AB
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Exosome Diagnostics
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousands)
  • Table 2. North America Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 3. North America Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 4. US Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 5. US Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 6. US Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 7. Canada Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 8. Canada Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 9. Canada Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 10. Mexico Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 11. Mexico Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 12. Mexico Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 13. Europe Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousands)
  • Table 14. Europe Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 15. Europe Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 16. Germany Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 17. Germany Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 18. Germany Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 19. France Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 20. France Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 21. France Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 22. UK Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 23. UK Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 24. UK Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 25. Italy Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 26. Italy Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 27. Italy Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 28. Spain Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 29. Spain Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 30. Spain Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 31. Asia Pacific Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousands)
  • Table 32. Asia Pacific Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 33. Asia Pacific Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 34. China Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 35. China Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 36. China Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 37. Japan Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 38. Japan Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 39. Japan Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 40. India Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 41. India Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 42. India Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 43. South Korea Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 44. South Korea Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 45. South Korea Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 46. Australia Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 47. Australia Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 48. Australia Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 49. Middle East and Africa Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousands)
  • Table 50. Middle East and Africa Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 51. Middle East and Africa Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 52. UAE Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 53. UAE Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 54. UAE Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 55. Saudi Arabia Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 56. Saudi Arabia Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 57. Saudi Arabia Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 58. South Africa Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 59. South Africa Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 60. South Africa Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 61. South and Central America Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 62. South and Central America Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 63. South and Central America Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 64. Brazil Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 65. Brazil Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 66. Brazil Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 67. Argentina Exosome Diagnostic and Therapeutic Market, by Application- Revenue and Forecast to 2027 (USD Thousand)
  • Table 68. Argentina Exosome Diagnostic and Therapeutic Market, by Product - Revenue and Forecast to 2027 (USD Thousand)
  • Table 69. Argentina Exosome Diagnostic and Therapeutic Market, by End User - Revenue and Forecast to 2027 (USD Thousand)
  • Table 70. Recent Inorganic Growth Strategies in The Exosome Diagnostic and Treatment Market
  • Table 71. Recent Organic Growth Strategies in The Exosome Diagnostic and Treatment Market
  • Table 72. Glossary of Terms, Exosome diagnostic and treatment market

LIST OF FIGURES

  • Figure 1. Exosome Diagnostic and Therapeutic Market Segmentation
  • Figure 2. Exosome Diagnostic and Therapeutic Segmentation, By Region
  • Figure 3. Global Exosome Diagnostic and Therapeutic Market Overview
  • Figure 4. Diagnostics Held Largest Share Of Application Segment In Exosome diagnostic and Therapeutic Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth during the Forecast Period
  • Figure 6. Global Exosome diagnostic and therapeutic Market, By Geography (US$ Million)
  • Figure 7. Global Exosome Diagnostic and Therapeutic Market- Leading Country Markets (US$ Thousand)
  • Figure 8. Global Exosome Diagnostic and Therapeutic Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South and central America PEST Analysis
  • Figure 14. Exosome diagnostic and therapeutic market impact analysis of driver and restraints
  • Figure 15. Global Exosome Diagnostic and Therapeutic Market- Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Exosome Diagnostic and Therapeutic Market- By Geography Forecast And Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Exosome Diagnostic and Therapeutic Market
  • Figure 18. Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
  • Figure 19. Diagnostic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 20. Therapeutic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 21. Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)
  • Figure 22. Instruments: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 23. Reagents: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 24. Software: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 25. Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)
  • Figure 26. Cancer Institutes: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 27. Hospitals: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 28. Diagnostic Centers: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 29. Other End Users: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
  • Figure 30. North America: Exosome Diagnostic and Therapeutic Market, by Key Country - Revenue (2019) (USD Thousand)
  • Figure 31. North America Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)
  • Figure 32. US: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 33. Canada: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 34. Mexico: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 35. Europe: Exosome Diagnostic and Therapeutic Market, by Key Country - Revenue (2019) (USD Thousand)
  • Figure 36. Europe Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)
  • Figure 37. Germany: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 38. France: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 39. UK: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 40. Italy: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 41. Spain: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 42. Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Key Country - Revenue (2019) (USD Thousand)
  • Figure 43. Asia Pacific Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)
  • Figure 44. China: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 45. Japan: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 46. India: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 47. South Korea: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 48. Australia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 49. Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Key Country - Revenue (2019) (USD Thousand)
  • Figure 50. Middle East and Africa Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)
  • Figure 51. UAE: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 52. Saudi Arabia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 53. South Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 54. South and Central America: Exosome Diagnostic and Therapeutic Market, by Key Country - Revenue (2019) (USD Thousand)
  • Figure 55. South and Central America Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousand)
  • Figure 56. South and Central America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
  • Figure 57. Brazil: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 58. Argentina: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
  • Figure 59. Impact Of Covid-19 Pandemic In North American Country Markets
  • Figure 60. Impact Of Covid-19 Pandemic In Europe Country Markets
  • Figure 61. Impact Of Covid-19 Pandemic In Asia-Pacific Country Markets
  • Figure 62. Impact Of Covid-19 Pandemic In Rest Of World Country Markets
  • Figure 63. Growth Strategies in the Exosome diagnostic and treatment Market, 2017-2020